FCGRT and infection: Transudation or active (FcRn-mediated) transport of bNAbs from circulation to mucosal tissues or secretions would position these effector molecules at the point of virus entry, where their neutralization or Fc-related antiviral functions may be expected to have greatest impact to prevent either initial infection or local amplification and systemic spread of a nascent infection48–51.